RegularLabs Articles Anywhere Extension cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00- |
Summary
A vulnerability described as problematic has been identified in RegularLabs Articles Anywhere Extension and Users Anywhere Extension. The affected element is an unknown function. The manipulation results in cross site scripting. This vulnerability is cataloged as CVE-2026-85196. The attack may be launched remotely. There is no exploit available.
Details
A vulnerability, which was classified as problematic, was found in RegularLabs Articles Anywhere Extension and Users Anywhere Extension (unknown version). Affected is an unknown code block. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
Joomla Extension - regularlabs.com - Reflected XSS in Articles Anywhere extension for Joomla < 20.0.0, Users Anywhere extension for Joomla < 2.1.0 - Articles Anywhere Pro and Users Anywhere Pro return values from request-input data tags without making them safe for the context in which the tag is used. Joomla's string input filter does not make the same value safe for HTML text, an HTML attribute and a URL. A visitor-controlled request value can therefore become an executable URL or a new event attribute in output configured by a site author.
The advisory is shared for download at regularlabs.com. This vulnerability is traded as CVE-2026-85196 since 09/03/2026. The exploitability is told to be easy. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
09/03/2026 CVE reserved09/14/2026 Advisory disclosed
09/14/2026 VulDB entry created
09/14/2026 VulDB entry last update
Sources
Advisory: regularlabs.comStatus: Not defined
CVE: CVE-2026-85196 (🔒)
GCVE (CVE): GCVE-0-2026-85196
GCVE (VulDB): GCVE-100-403464
Entry
Created: 09/14/2026 09:18Changes: 09/14/2026 09:18 (62)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.